ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2010 | 70.08 Million USD | 28.28% |
| 2009 | 54.63 Million USD | 107218.79% |
| 2008 | 50.9 Thousand USD | -73.84% |
| 2007 | 194.57 Thousand USD | 58.85% |
| 2006 | 122.48 Thousand USD | 44.45% |
| 2005 | 84.79 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2011 Q1 | 74.23 Million USD | 5.92% |
| 2011 Q3 | 82.86 Million USD | 10.26% |
| 2011 Q2 | 75.15 Million USD | 1.24% |
| 2010 Q3 | 68.28 Million USD | 8.14% |
| 2010 Q2 | 63.14 Million USD | 2.7% |
| 2010 FY | 70.08 Million USD | 28.28% |
| 2010 Q1 | 61.48 Million USD | 12.55% |
| 2010 Q4 | 70.08 Million USD | 2.63% |
| 2009 Q2 | 203.44 Thousand USD | 338.62% |
| 2009 Q4 | 54.63 Million USD | 17.34% |
| 2009 FY | 54.63 Million USD | 107218.79% |
| 2009 Q1 | 46.38 Thousand USD | -8.89% |
| 2009 Q3 | 46.55 Million USD | 22785.04% |
| 2008 FY | 50.9 Thousand USD | -73.84% |
| 2008 Q3 | 30.09 Thousand USD | -50.82% |
| 2008 Q4 | 50.9 Thousand USD | 69.18% |
| 2008 Q2 | 61.18 Thousand USD | -18.76% |
| 2008 Q1 | 75.31 Thousand USD | -61.29% |
| 2007 FY | 194.57 Thousand USD | 58.85% |
| 2007 Q2 | 73.05 Thousand USD | -7.65% |
| 2007 Q3 | 96.26 Thousand USD | 31.77% |
| 2007 Q4 | 194.57 Thousand USD | 102.12% |
| 2007 Q1 | 79.1 Thousand USD | -35.42% |
| 2006 Q4 | 122.48 Thousand USD | 0.0% |
| 2006 FY | 122.48 Thousand USD | 44.45% |
| 2005 FY | 84.79 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -3033904.545% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -3479.098% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -564.066% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -12593.89% |
| Rebus Holdings, Inc. | 5000.00 USD | -1401610.1% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 46.175% |
| Qrons Inc. | 420.00 USD | -16686925.0% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -8994.407% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -150.807% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -14484.223% |
| Skye Bioscience, Inc. | 11.94 Million USD | -486.961% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -80.414% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -870.745% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -91690.221% |
| SQZ Biotechnologies Company | 107.18 Million USD | 34.614% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -4794.13% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -96750.003% |
| Mesoblast Limited | 667.9 Million USD | 89.507% |
| Marizyme, Inc. | 22.01 Million USD | -218.352% |
| Genus plc | 1.02 Billion USD | 93.188% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -5059.594% |
| Pharming Group N.V. | 462.85 Million USD | 84.858% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -2015.462% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -13944.094% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -11077.911% |
| ContraFect Corporation | 20.67 Million USD | -238.921% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -17853.793% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -18238.494% |
| IMV Inc. | 31.33 Million USD | -123.674% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -1590.428% |
| MultiCell Technologies, Inc. | 126.22 USD | -55526365.695% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -7358.372% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 45.463% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -16134.244% |
| Q BioMed Inc. | 3.51 Million USD | -1893.604% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -99.225% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -26724.215% |
| Biomind Labs Inc. | 73.81 Thousand USD | -94842.366% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 84.297% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -4737.343% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -133.502% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -2451.965% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -10094.463% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -2592.287% |
| GB Sciences, Inc. | 103.44 Thousand USD | -67653.432% |
| Alpha Cognition Inc. | 2.45 Million USD | -2758.101% |
| HST Global, Inc. | 1526.00 USD | -4592659.174% |
| CSL Limited | 38.02 Billion USD | 99.816% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -6993.912% |
| Halberd Corporation | 10.13 Thousand USD | -691692.567% |
| Enzolytics Inc. | 361.7 Million USD | 80.624% |
| Agentix Corp. | 261.39 Thousand USD | -26712.414% |
| Resverlogix Corp. | 8.11 Million USD | -763.654% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -3632.161% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 98.457% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -46.924% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -10856.749% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -307548.94% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -683.152% |
| AVAX Technologies, Inc. | 7.37 Million USD | -850.034% |
| Zenith Capital Corp. | 7410.00 USD | -945723.279% |
| Genscript Biotech Corporation | 3.38 Billion USD | 97.93% |
| Ember Therapeutics, Inc. | 184.00 USD | -38089848.37% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -21678.806% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -26715.286% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -7452.635% |
| Kadimastem Ltd | 2.3 Million USD | -2941.8% |
| Helix BioMedix, Inc. | 3.02 Million USD | -2216.81% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -32.987% |
| BioStem Technologies, Inc. | 14.56 Million USD | -381.347% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -122654.589% |
| LadRx Corporation | 2.3 Million USD | -2936.789% |
| Cell Source, Inc. | 195.17 Thousand USD | -35809.794% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -19719.609% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -19719.609% |
| NovAccess Global Inc. | 62.24 Thousand USD | -112490.774% |
| Affymax, Inc. | 7.44 Million USD | -841.63% |
| Itoco Inc. | 1.4 Million USD | -4905.85% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -73167.513% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -66018.401% |
| Mobile Lads Corp. | 52.00 USD | -134779717.308% |
| CytoDyn Inc. | 11.13 Million USD | -529.36% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -48920.441% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -391877.097% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -18081.784% |
| SYBLEU INC | 330.46 Thousand USD | -21107.955% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -17018.158% |
| International Stem Cell Corporation | 5.39 Million USD | -1200.288% |
| Bioxytran, Inc. | 137.63 Thousand USD | -50820.171% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -367.18% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -322.737% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -88615.829% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -8005.397% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -832.36% |
| Neutra Corp. | 2851.00 USD | -2458177.973% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -116.273% |
| PureTech Health plc | 693.97 Million USD | 89.901% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -768.353% |
| IXICO plc | 15.84 Million USD | -342.35% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -746.239% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 32.169% |
| CSL Limited | 38.02 Billion USD | 99.816% |
| Cellectis S.A. | 333.99 Million USD | 79.016% |